Clinical Trial Update: Open Label Single Arm Prebiotic Pilot Trial SR001 [NA]

View source ↗

Summary

An open-label, single-arm prebiotic pilot trial SR001 conducted by Sorridi Therapeutics has completed. The study enrolled participants with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Sorridi Therapeutics | Conditions: PARKINSON DISEASE (Disorder) | NA | Status: COMPLETED